NCT04899661View on ClinicalTrials.gov

A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

Active, not recruitingOBSERVATIONAL
Enrollment

1,081

Participants

Timeline

Start Date

August 6, 2021

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Renal Anemia
Interventions
DRUG

Molidustat (Musredo, BAY85-3934)

Tablets, administered orally at the discretion of investigators

Trial Locations (1)

Unknown

Many facilities, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY